Applikon brings advanced upstream technologies to BPI Europe
Press Release | Applikon Biotechnology B.V.
APRIL 17, 2018
Delft, The Netherlands: – Dutch-based upstream bioprocess equipment specialist Applikon Biotechnology B.V. (Applikon) will be bringing its significant advances and new solutions to the upcoming BioProcess International European Summit, BPI Europe, in Amsterdam.
Applikon will be both a sponsor and exhibitor at the summit, with its stand at Booth 103 at the RAI Center showcasing a range of advanced management and software solutions.
Advanced software solutions
These include the Lucullus PIMS Process Information Management System, a single software solution designed to manage all bioprocess functions and instrumentation from experimental design to planning, execution, data analysis and reporting.
Applikon will also be showing its associated DetlaV based software solution V-Control, the automation solution designed for laboratory bioreactor systems.
Advanced upstream bioprocessing presentation
On Day Three of the Summit, (Wednesday, 25 April, 15:05hrs) Applikon will use its Speaker Slot for Product Manager Cristina Bernal Martinez to deliver a 30-minute presentation on “Screening conditions of monitored CHO cell culture using 24 parallel micro bioreactors”.
“We are looking forward very much to returning to BPI Europe which is a great platform for us to connect with all those end-users, distributors, bioprocessing professionals and scientists looking for advanced upstream bioprocessing solutions,” commented Ms. Martinez.
About Applikon Biotechnology
Netherlands-based Applikon Biotechnology B.V. (Applikon) is a manufacturer that specializes in upstream bioprocess equipment for the life sciences industries. Its mission is to provide reliable solutions for the bioprocess market to enable improved quality of life.
Applikon’s core business is in the development and supply of advanced bioreactor systems from laboratory scale, to pilot, to production scale, partnering with customers to implement scalable platforms from initial screening through development and full-scale production for a global client
base that includes pharma and biotech companies, food industry, CROs, CMOs, governmental and academic organizations.
Applikon designs, develops and assembles bioreactor systems, with all design and manufacturing conducted in-house. The Applikon portfolio covers key product and service areas including bioreactor cultivation systems, BioBundle turnkey systems, the unique BioSep Acoustic Perfusion System cell
retention device, process control systems to automate bioprocesses and a range of proprietary Applisens sensors, and automation (monitoring and data management) solutions.
Apart from its standard cultivation and turnkey systems, Applikon also offers Special Projects: custom solutions aimed at helping clients fulfil strategic needs such as long-term development, capability expansion and upscaling.
Applikon is headquartered at Delft in The Netherlands with subsidiaries in the UK, New Jersey and California, USA and a distributor network covering more than 35 countries.
About BPI Europe 2018
The BioProcess International European Summit (BPI Europe) is one of the world’s largest events dedicated to bioprocessing, highlighting the sciences, technologies and partners needed to accelerate promising biologics to market.
BPI Europe 2018 is a three-day event opening April 23 at the RAI Conference Center in Amsterdam.
The conference is expected to attract more than 900 scientists and executives representing some 275 companies and organizations working across the entire bioprocessing spectrum. The co-located exhibition will feature more than 160 leading companies.
The event is organized by Knect365 with more information at: https://lifesciences.knect365.com/bpieurope/.
Media Department, Applikon Biotechnology B.V.